Literature DB >> 11327703

Significance of cathepsin B accumulation in synovial fluid of rheumatoid arthritis.

Y Hashimoto1, H Kakegawa, Y Narita, Y Hachiya, T Hayakawa, J Kos, V Turk, N Katunuma.   

Abstract

We measured and compared the activities of various kinds of proteinases, such as cysteine, serine, aspartic, and metalloproteinases, in synovial fluids of 16 patients with rheumatoid arthritis (RA) and 18 patients with osteoarthritis (OA). More than 19-fold higher activity of cathepsin B and about 6-fold higher activity of prolylendopeptidase, compared to those of OA, were accumulated in RA fluid. Moreover, levels of cathepsins B and S using the corresponding sandwich enzyme immunoassays were statistically higher in RA fluid than those in OA. Significant amounts of 41-kDa and 35-kDa procathepsin L were detected in RA fluid using gelatin zymography, while 41-kDa enzyme alone was detected in OA. Cathepsin B in RA fluid could degrade collagen, and this degradation was suppressed by the addition of CA-074, a specific inhibitor of cathepsin B. Therefore, cathepsin B may participate in joint destruction of RA, and its inhibitor may be effective for RA care.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11327703     DOI: 10.1006/bbrc.2001.4787

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  34 in total

1.  Serum cysteine proteases and their inhibitors in rheumatoid arthritis: relation to disease activity and radiographic progression.

Authors:  Iben Jørgensen; Janko Kos; Marta Krašovec; Lone Troelsen; Mette Klarlund; Trine W Jensen; Michael S Hansen; Søren Jacobsen
Journal:  Clin Rheumatol       Date:  2010-10-06       Impact factor: 2.980

2.  Polypeptide nanogels with hydrophobic moieties in the cross-linked ionic cores: synthesis, characterization and implications for anticancer drug delivery.

Authors:  Jong Oh Kim; Hardeep S Oberoi; Swapnil Desale; Alexander V Kabanov; Tatiana K Bronich
Journal:  J Drug Target       Date:  2013-09-02       Impact factor: 5.121

3.  Bone microenvironment modulates expression and activity of cathepsin B in prostate cancer.

Authors:  Izabela Podgorski; Bruce E Linebaugh; Mansoureh Sameni; Christopher Jedeszko; Sunita Bhagat; Michael L Cher; Bonnie F Sloane
Journal:  Neoplasia       Date:  2005-03       Impact factor: 5.715

4.  Cathepsin B: Basis Sequence: Mouse.

Authors:  Dora Cavallo-Medved; Kamiar Moin; Bonnie Sloane
Journal:  AFCS Nat Mol Pages       Date:  2011-04-10

5.  Split top: a maternal cathepsin B that regulates dorsoventral patterning and morphogenesis.

Authors:  Yvette G Langdon; Ricardo Fuentes; Hong Zhang; Elliott W Abrams; Florence L Marlow; Mary C Mullins
Journal:  Development       Date:  2016-02-18       Impact factor: 6.868

6.  Crystal structure of NS-134 in complex with bovine cathepsin B: a two-headed epoxysuccinyl inhibitor extends along the entire active-site cleft.

Authors:  Igor Stern; Norbert Schaschke; Luis Moroder; Dusan Turk
Journal:  Biochem J       Date:  2004-07-15       Impact factor: 3.857

7.  Role of cathepsin B in regulating migration and invasion of fibroblast-like synoviocytes into inflamed tissue from patients with rheumatoid arthritis.

Authors:  B Tong; B Wan; Z Wei; T Wang; P Zhao; Y Dou; Z Lv; Y Xia; Y Dai
Journal:  Clin Exp Immunol       Date:  2014-09       Impact factor: 4.330

8.  Inhibition of cathepsin B activity by 2,3,7,8-tetrachlorodibenzo-p-dioxin.

Authors:  Mateusz Kędzior; Rafał Seredyński; Urszula Godzik; Dagmara Tomczyk; Jan Gutowicz; Ewa Terlecka; Ireneusz Całkosiński; Grzegorz Terlecki
Journal:  Environ Sci Pollut Res Int       Date:  2014-08-28       Impact factor: 4.223

9.  Biodegradable hybrid polymer micelles for combination drug therapy in ovarian cancer.

Authors:  Swapnil S Desale; Samuel M Cohen; Yi Zhao; Alexander V Kabanov; Tatiana K Bronich
Journal:  J Control Release       Date:  2013-05-09       Impact factor: 9.776

10.  Rational Design of a Humanized Antibody Inhibitor of Cathepsin B.

Authors:  Zhefu Dai; Qinqin Cheng; Yong Zhang
Journal:  Biochemistry       Date:  2020-03-31       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.